Chaowen Yu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Renal and related cancers
Papers in
-
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 3
- Renal and related cancers 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Ran Lu (8 shared papers)Lin Zou (6 shared papers)Wenbo Tang (4 shared papers)Tao Song (5 shared papers)Hao Liu (6 shared papers)Shiyuan Chen (7 shared papers)Juan Zhang (5 shared papers)Xiaohou Wu (3 shared papers)
- Journals
- Analytical and Bioanalytical Chemistry (2 papers)The Prostate (1 paper)Journal of Proteomics (1 paper)Journal of Cellular Biochemistry (1 paper)BMC Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chaowen Yu
37 papers receiving 370 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 109
- Molecular Biology 177
- Genetics 20
- Clinical Biochemistry 13
- Hematology 20
Countries citing papers authored by Chaowen Yu
This map shows the geographic impact of Chaowen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaowen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaowen Yu more than expected).
Fields of papers citing papers by Chaowen Yu
This network shows the impact of papers produced by Chaowen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaowen Yu. The network helps show where Chaowen Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaowen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 37 | |
| 2 | 2011 | 27 | |
| 3 | 2016 | 27 | |
| 4 | 2016 | 26 | |
| 5 | 2022 | 26 | |
| 6 | 2019 | 23 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2019 | 16 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 11 | |
| 14 | PLCε knockdown prevents serine/glycine metabolism and proliferation of prostate cancer by suppressing YAP. | 2020 | 11 |
| 15 | 2015 | 10 | |
| 16 | 1998 | 9 | |
| 17 | 2021 | 9 | |
| 18 | miR-107 inhibits PDGF-BB-induced proliferation of human pulmonary arterial smooth muscle cells and migration through targeting NOR1. | 2019 | 7 |
| 19 | 2023 | 6 | |
| 20 | 2023 | 5 |
About Chaowen Yu
Chaowen Yu is a scholar working on Molecular Biology, Cancer Research, Clinical Biochemistry, Genetics and Surgery, having authored 40 papers that have together received 373 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Metabolism and Genetic Disorders (5 papers), Genetic and Kidney Cyst Diseases (4 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers), Renal and related cancers (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Cancer Research (109 citations), Molecular Biology (177 citations), Genetics (20 citations), Clinical Biochemistry (13 citations) and Hematology (20 citations). Chaowen Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ran Lu, Lin Zou, Wenbo Tang, Tao Song, Hao Liu, Shiyuan Chen, Juan Zhang, Xiaohou Wu, Ke-Xing Wan and Yong Gao. Their work appears in journals such as Analytical and Bioanalytical Chemistry, The Prostate, Journal of Proteomics, Journal of Cellular Biochemistry and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.